511 related articles for article (PubMed ID: 23466435)
21. Establishment of a statewide network for carbapenem-resistant enterobacteriaceae prevention in a low-incidence region.
Pfeiffer CD; Cunningham MC; Poissant T; Furuno JP; Townes JM; Leitz A; Thomas A; Buser GL; Arao RF; Beldavs ZG
Infect Control Hosp Epidemiol; 2014 Apr; 35(4):356-61. PubMed ID: 24602939
[TBL] [Abstract][Full Text] [Related]
22. Healthcare Antibiotic Resistance Prevalence - DC (HARP-DC): A Regional Prevalence Assessment of Carbapenem-Resistant Enterobacteriaceae (CRE) in Healthcare Facilities in Washington, District of Columbia.
Reuben J; Donegan N; Wortmann G; DeBiasi R; Song X; Kumar P; McFadden M; Clagon S; Mirdamadi J; White D; Harris JE; Browne A; Hooker J; Yochelson M; Walker M; Little G; Jernigan G; Hansen K; Dockery B; Sinatro B; Blaylock M; Harmon K; Iyengar P; Wagner T; Nelson JA;
Infect Control Hosp Epidemiol; 2017 Aug; 38(8):921-929. PubMed ID: 28615088
[TBL] [Abstract][Full Text] [Related]
23. Fast and expensive (PCR) or cheap and slow (culture)? A mathematical modelling study to explore screening for carbapenem resistance in UK hospitals.
Knight GM; Dyakova E; Mookerjee S; Davies F; Brannigan ET; Otter JA; Holmes AH
BMC Med; 2018 Aug; 16(1):141. PubMed ID: 30111322
[TBL] [Abstract][Full Text] [Related]
24. Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012.
Logan LK; Renschler JP; Gandra S; Weinstein RA; Laxminarayan R; ;
Emerg Infect Dis; 2015 Nov; 21(11):2014-21. PubMed ID: 26486124
[TBL] [Abstract][Full Text] [Related]
25. Outcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit medical center.
Marchaim D; Chopra T; Perez F; Hayakawa K; Lephart PR; Bheemreddy S; Blunden C; Hujer AM; Rudin S; Shango M; Campbell M; Varkey J; Slim J; Ahmad F; Patel D; Chen TY; Pogue JM; Salimnia H; Dhar S; Bonomo RA; Kaye KS
Infect Control Hosp Epidemiol; 2011 Sep; 32(9):861-71. PubMed ID: 21828966
[TBL] [Abstract][Full Text] [Related]
26. Notes from the Field: Carbapenem-resistant Enterobacteriaceae Producing OXA-48-like Carbapenemases--United States, 2010-2015.
Lyman M; Walters M; Lonsway D; Rasheed K; Limbago B; Kallen A
MMWR Morb Mortal Wkly Rep; 2015 Dec; 64(47):1315-6. PubMed ID: 26633574
[TBL] [Abstract][Full Text] [Related]
27. Carbapenem-Resistant Enterobacteriaceae Transmission in Health Care Facilities - Wisconsin, February-May 2015.
Elbadawi LI; Borlaug G; Gundlach KM; Monson T; Warshauer D; Walters MS; Kallen A; Gulvik CA; Davis JP
MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(34):906-9. PubMed ID: 27584864
[TBL] [Abstract][Full Text] [Related]
28. Carbapenem-resistant Enterobacteriaceae and the correlation between carbapenem and fluoroquinolone usage and resistance in the US military health system.
Lesho EP; Clifford RJ; Chukwuma U; Kwak YI; Maneval M; Neumann C; Xie S; Nielsen LE; Julius MD; McGann P; Waterman PE
Diagn Microbiol Infect Dis; 2015 Feb; 81(2):119-25. PubMed ID: 25497458
[TBL] [Abstract][Full Text] [Related]
29. Ten-year resistance trends in pathogens causing healthcare-associated infections; reflection of infection control interventions at a multi-hospital healthcare system in Saudi Arabia, 2007-2016.
Balkhy HH; El-Saed A; Alshamrani MM; Alsaedi A; Al Nasser W; El Gammal A; Aljohany SM; Almunif S; Arabi Y; Alqahtani S; Bonnie HB; Alghoribi M; Alothman A; Almohrij SA
Antimicrob Resist Infect Control; 2020 Jan; 9(1):21. PubMed ID: 32000850
[TBL] [Abstract][Full Text] [Related]
30. Clinical epidemiology of carbapenem-resistant enterobacteriaceae in community hospitals: a case-case-control study.
Lee GC; Lawson KA; Burgess DS
Ann Pharmacother; 2013 Sep; 47(9):1115-21. PubMed ID: 24259725
[TBL] [Abstract][Full Text] [Related]
31. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.
Dickstein Y; Edelman R; Dror T; Hussein K; Bar-Lavie Y; Paul M
J Hosp Infect; 2016 Sep; 94(1):54-9. PubMed ID: 27392978
[TBL] [Abstract][Full Text] [Related]
32. Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy.
Viale P; Tumietto F; Giannella M; Bartoletti M; Tedeschi S; Ambretti S; Cristini F; Gibertoni C; Venturi S; Cavalli M; De Palma A; Puggioli MC; Mosci D; Callea E; Masina R; Moro ML; Lewis RE
Clin Microbiol Infect; 2015 Mar; 21(3):242-7. PubMed ID: 25658534
[TBL] [Abstract][Full Text] [Related]
33. "Nightmare" bacteria on the rise in US hospitals, long-term care facilities.
Kuehn BM
JAMA; 2013 Apr; 309(15):1573-4. PubMed ID: 23592085
[No Abstract] [Full Text] [Related]
34. A systematic review of the epidemiology of carbapenem-resistant Enterobacteriaceae in the United States.
Livorsi DJ; Chorazy ML; Schweizer ML; Balkenende EC; Blevins AE; Nair R; Samore MH; Nelson RE; Khader K; Perencevich EN
Antimicrob Resist Infect Control; 2018; 7():55. PubMed ID: 29719718
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of carbapenem-resistant Enterobacteriaceae in hospitals of a large healthcare system in Miami, Florida from 2012 to 2016: Five years of experience with an internal registry.
Jimenez A; Trepka MJ; Munoz-Price LS; Pekovic V; Ibrahimou B; Abbo LM; Martinez O; Sposato K; dePascale D; Perez-Cardona A; McElheny CL; Bachman WC; Fowler EL; Doi Y; Fennie K
Am J Infect Control; 2020 Nov; 48(11):1341-1347. PubMed ID: 32334004
[TBL] [Abstract][Full Text] [Related]
36. Rapid Increase in Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) and Emergence of Colistin Resistance Gene
Li Y; Sun QL; Shen Y; Zhang Y; Yang JW; Shu LB; Zhou HW; Wang Y; Wang B; Zhang R; Wang S; Shen Z
J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29386265
[TBL] [Abstract][Full Text] [Related]
37. Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study.
Teo JQ; Chang CW; Leck H; Tang CY; Lee SJ; Cai Y; Ong RT; Koh TH; Tan TT; Kwa AL
Int J Antimicrob Agents; 2019 May; 53(5):657-662. PubMed ID: 30880229
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of multidrug-resistant Enterobacteriaceae in Sri Lanka: First evidence of bla
Kumudunie WGM; Wijesooriya LI; Namalie KD; Sunil-Chandra NP; Wijayasinghe YS
J Infect Public Health; 2020 Sep; 13(9):1330-1335. PubMed ID: 32439355
[TBL] [Abstract][Full Text] [Related]
39. Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States.
Bartsch SM; McKinnell JA; Mueller LE; Miller LG; Gohil SK; Huang SS; Lee BY
Clin Microbiol Infect; 2017 Jan; 23(1):48.e9-48.e16. PubMed ID: 27642178
[TBL] [Abstract][Full Text] [Related]
40. Asymptomatic rectal colonization with carbapenem-resistant Enterobacteriaceae and Clostridium difficile among residents of a long-term care facility in New York City.
Prasad N; Labaze G; Kopacz J; Chwa S; Platis D; Pan CX; Russo D; LaBombardi VJ; Osorio G; Pollack S; Kreiswirth BN; Chen L; Urban C; Segal-Maurer S
Am J Infect Control; 2016 May; 44(5):525-32. PubMed ID: 26796684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
